10/ 12/ 2026
FDA Updates Nonclinical Testing Rules to Expand Regulatory Pathways for NAMs
FDA updates nonclinical testing terminology, supporting broader use of scientifically valid NAMs in drug development while maintaining safety standards.
10/ 12/ 2026
Strengthening Global Connections and Advancing Pharmaceutical Partnerships | Loncom at CPHI Milan 2026
LONCOM connects global pharmaceutical partners through API supply, finished dosage forms, pharmaceutical R&D, and contract manufacturing solutions.
09/ 18/ 2026
FDA Publishes 55 Draft Product-Specific Guidances, Further Refining Pathways for Complex Generic Drug Development
FDA’s latest 55 draft PSGs further clarify generic drug development, with continued focus on complex products and science-based BE approaches.
